Surgical Glue Market Size, Share, 2032
Surgical Glue Market Size and Forecast (2025 - 2032), By Product Type (Natural, Synthetic), By Application (Cardiac Surgery, Neurosurgery, General Surgery, Orthopedic Surgery, Others), By End-User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), and Geography.
Market Overview:
“The Surgical Glue Market is expected to reach a high CAGR of 8.2% over the Forecast Period 2025-2032, reaching a value of USD 6.5 billion by 2032.”
North America dominates the market, accounting for 40% of the world share. Key measures include increasing surgical procedures, growing prevalence of chronic diseases, and rising adoption of minimally invasive surgeries.
The surgical glue industry is expanding rapidly, owing to technological advances in adhesive compositions and an increased demand for non-invasive closure techniques. The industry is shifting towards bio-based and biodegradable surgical adhesives, with producers focussing on creating solutions with improved biocompatibility and wound healing capabilities.
Surgical Glue Market Dynamics:
Market Trend: Shift towards bio-based and biodegradable surgical adhesives
The surgical glue market is seeing a considerable transition towards bio-based and biodegradable solutions. This trend is primarily driven by increased worries about the environmental impact of synthetic materials, as well as an increase in demand for biocompatible surgical equipment. Bio-based surgical adhesives provide several advantages, including a lower risk of allergic responses, greater tissue integration, and wound healing characteristics.
Bio-based surgical adhesives accounted for 35% of the market in 2023, with a predicted CAGR of 9.5% between 2024 and 2031. The expanding use of these adhesives in a variety of surgical applications, particularly in sensitive tissues and organs, is driving this expansion.
Recent industry breakthroughs include the introduction of enhanced bio-based surgical adhesive compositions. For example, in 2023, a leading medical equipment manufacturer introduced a revolutionary plant-derived surgical glue that outperformed standard synthetic adhesives in terms of strength and flexibility.
Market Driver: Rising prevalence of chronic diseases and increasing surgical procedures
The increased frequency of chronic diseases, as well as the following increase in surgical operations, are major drivers of the surgical glue market. Surgical adhesives are frequently employed in a variety of operations, including cardiovascular, orthopaedic, and general surgeries, due to their ability to enable quick and successful wound closure.
According to the World Health Organisation, chronic diseases account for 71% of all deaths worldwide each year. This has resulted in a boom in surgical procedures, with an expected 310 million major surgeries done globally by 2023. Surgical glues are essential in these treatments, providing advantages such as shorter operating times, less scarring, and better patient outcomes.
Furthermore, the expanding aging population is driving up the demand for surgical operations. The global population of 65 and older will reach 750 million by 2023, with this demographic group being more likely to require surgical treatments. This trend is likely to propel the surgical glue market forward, with a 15% year-on-year increase in utilisation across geriatric operations.
Market Restraint: Stringent regulatory approval processes and high development costs
The surgical adhesive industry confronts major challenges due to strict regulatory clearance processes and high research costs. New surgical glues, classified as Class III medical devices, require rigorous clinical studies and safety evaluations, with clearance taking 3 to 7 years and expenditures frequently reaching $100 million. This lengthy procedure discourages small businesses and hampers innovation. Furthermore, differences in regulatory standards between areas hamper global commercialisation, since items licensed in one region may require extra data or alterations in another. To address these concerns, several corporations prioritise refining existing formulas over inventing new, possibly innovative goods.
Segment Overview:
Synthetic surgical adhesives dominate the market, accounting for 65% of the global market share.
Synthetic surgical adhesives have emerged as the dominating sector in the surgical glue market, accounting for 65% of the global market share. This supremacy is due to their versatility, strong adhesive capabilities, and broad range of applications across a variety of surgical procedures.
Synthetic surgical adhesives have various advantages, including quick polymerisation, high tensile strength, and the ability to customize to specific tissue types. These factors have contributed to their extensive use in various surgical specialities.
Over the last two years, the use of synthetic surgical adhesives in cardiovascular surgery has increased by 20%. The increasing number of coronary artery bypass grafting (CABG) procedures, as well as the adhesives' efficiency in sealing vascular anastomoses, are driving this rise.
Synthetic surgical adhesives have also gained popularity in neurosurgery, with adoption rates increasing by 15% year on year. This increase is due to the adhesives' capacity to provide good dural sealing while lowering the danger of cerebrospinal fluid leaks.
Recent advances in synthetic surgical adhesive technology have aimed to improve biocompatibility and reduce the risk of tissue irritation. A renowned medical device maker has unveiled a new generation of synthetic surgical adhesives with bioabsorbable components, which provide better tissue integration and fewer long-term issues.
Regional Outlook:
North America leads the surgical glue market, driven by advanced healthcare infrastructure and high adoption of innovative medical technologies.
North America dominates the global surgical glue market, with over 40% of the market share. The region's dominant position is largely due to its superior healthcare infrastructure, high healthcare spending, and early adoption of novel medical technologies.
The United States is the region's top consumer of surgical adhesives. In 2023, the US surgical glue market was worth USD 1.2 billion, with a 7.8% CAGR forecast through 2031. The huge volume of surgical procedures performed each year, along with a rising desire for minimally invasive treatments, is driving this development.
The FDA recently approved a unique synthetic surgical adhesive particularly for use in eye procedures. This approval is projected to greatly increase the use of surgical glues in sensitive eye surgeries, perhaps creating a new market niche.
The North American surgical glue market is expected to reach USD 2.1 billion by 2031, expanding at an 8.2% CAGR from 2024 to 2031. Hospitals consume 70% of the region's surgical adhesives, with ambulatory surgical centres accounting for 20%.
The use of bio-based surgical adhesives in Canada has increased significantly, notably in paediatric procedures. The country's emphasis on environmentally friendly medical products and patient safety has resulted in a 25% increase in the use of bio-based surgical glues in children's hospitals over the last year.
Competitive Intelligence:
The surgical glue market is characterised by fierce rivalry among prominent competitors vying for market dominance through product innovation, strategic partnerships, and global growth. Leading businesses including Johnson & Johnson, Baxter International Inc., and B. Braun Melsungen AG account for roughly 45% of the global market.
Johnson & Johnson has maintained its market leadership with a 20% share by exploiting its excellent R&D skills and varied product line. The company's recent introduction of a new synthetic surgical adhesive with improved haemostatic characteristics has boosted its position in the cardiovascular surgery market.
Baxter International Inc. has sought to extend its global footprint through strategic acquisitions and investments in new markets. In 2023, the firm purchased a top regional manufacturer of surgical sealants in Asia, expanding its manufacturing capacity and distribution network in the region.
B. Braun Melsungen AG has prioritised product innovation and digital health integration to sustain its competitive advantage. Surgeons in Europe have responded positively to the company's recent release of a smart surgical adhesive applicator device that delivers real-time input on adhesive viscosity and coverage.
Emerging firms such as Adhesys Medical GmbH and Gecko Biomedical are gaining traction by focussing on the development of novel bio-inspired surgical adhesives. These firms are heavily investing in biomimetic technology to develop adhesives that imitate natural biological processes, which could revolutionise tissue repair and wound closure approaches.
Looking ahead, the competitive landscape is expected to shift, with a greater emphasis on multifunctional surgical adhesives, the incorporation of nanotechnology into adhesive formulations, and the development of personalised surgical glues tailored to specific patient characteristics and surgical needs.
Analyst Opinion:
The surgical glue market is undergoing a substantial shift, owing to technological improvements and rising demand for minimally invasive surgical techniques. As healthcare professionals prioritise patient outcomes and cost-effectiveness, surgical adhesives will play an increasingly important role in modern surgical operations.
One unique technique that is gaining traction is the development of "smart" surgical adhesives. These new formulations include sensors and responsive elements that can adjust to the wound environment, giving real-time data on wound healing process and identifying early signs of infection. Early clinical trials with these smart adhesives have yielded encouraging results in terms of lowering post-operative problems and enhancing patient monitoring.
Another important discovery is the combination of surgical adhesives and regenerative medicine. We are seeing the rise of bioactive surgical glues that not only seal wounds but also actively encourage tissue regeneration and angiogenesis. This tendency is especially essential in difficult wound treatment and organ rebuilding surgeries, where standard sutures or staples may not be sufficient.
The trend towards personalised treatment is also fuelling innovation in the surgical glue sector. We predict an increase in demand for surgical adhesives that can be customised based on unique patient characteristics such as tissue type, healing capacity, and probable allergic reactions. This personalised strategy has the potential to greatly improve surgical outcomes while lowering the likelihood of adverse responses.
As the market develops, we anticipate a confluence of surgical adhesive technologies with other advanced medical technologies, such as 3D bioprinting and robotic surgery. This combination could result in the creation of very precise, automated adhesive application systems, increasing the efficiency and accuracy of surgical procedures.
Major Players:
-
Johnson & Johnson
-
Baxter International Inc.
-
B. Braun Melsungen AG
-
Becton, Dickinson and Company
-
Medtronic plc
-
CryoLife, Inc.
-
Cohera Medical, Inc.
-
Adhezion Biomedical, LLC
-
Chemence Medical, Inc.
-
Teleflex Incorporated
-
Adhesys Medical GmbH
-
Gecko Biomedical
Key Developments:
-
June 2024: Johnson & Johnson launched a new generation of synthetic surgical adhesives incorporating nanotechnology, offering enhanced tissue integration and antimicrobial properties.
-
April 2024: Baxter International Inc. announced a strategic partnership with a leading robotics company to develop an automated surgical glue application system for minimally invasive procedures.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope & Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking – Key Players
3.3. Market Share Analysis – Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES
- Johnson & Johnson
- Baxter International Inc.
- B. Braun Melsungen AG
- Becton, Dickinson and Company
- Medtronic plc
- CryoLife, Inc.
- Cohera Medical, Inc.
- Adhezion Biomedical, LLC
- Chemence Medical, Inc.
- Teleflex Incorporated
- Adhesys Medical GmbH
- Gecko Biomedical
5. MARKET DYNAMICS
5.1. Market Trends
5.2. Market Drivers
5.3. Market Restraints
5.4. Porter's Five Forces Analysis
5.5. Supply Chain Analysis
5.6. Value Chain Analysis
5.7. Regulatory Analysis
5.8. Patent Analysis
5.9. PESTLE Analysis
5.10. Market Opportunities
6. BY PRODUCT TYPE (MARKET VALUE (US$ MILLION) – 2025-2032*)
6.1. Natural
6.2. Synthetic
7. BY APPLICATION
7.1. Cardiac Surgery
7.2. Neurosurgery
7.3. General Surgery
7.4. Orthopedic Surgery
7.5. Others
8. BY END-USER
8.1. Hospitals
8.2. Specialty Clinics
8.3. Ambulatory Surgical Centers
9. BY REGION
9.1. North America
9.1.1. United States
9.1.2. Canada
9.1.3. Mexico
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Australia
9.3.5. South Korea
9.3.6. Rest of Asia-Pacific
9.4. Latin America
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Rest of Latin America
9.5. Middle East & Africa
9.5.1. UAE
9.5.2. Saudi Arabia
9.5.3. South Africa
9.5.4. Rest of Middle East & Africa
By Product Type:
- Natural
- Synthetic
By Application:
- Cardiac Surgery
- Neurosurgery
- General Surgery
- Orthopedic Surgery
- Others
By End-User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Frequently Asked Questions
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511